Expression :

Owner Public
URN urn:agi-Expression:inout-urn:agi-cas:167869-21-8:out-urn:agi-llid:5468::negative
Entities PPARG |--- PD98059
References 5
Connectivity 2
Effect negative

Organism Mus musculus
Journal Endocrinology
Journal Reference v140 i1 p392 (1999)
Journal Link http://endo.endojournals.org/cgi/content/full/140/1/392
MedLine Reference 9886850:1085
Sentence As previously reported ( 15 ), this treatment caused a significant increase in PPARgamma phosphorylation that was completely blocked by PD98059 (Fig. 2a , lanes 3 and 4).

CellLineName THP I
Journal J. Biol. Chem
CellType macrophage
Journal Reference v275 i2 p1241 (2000)
Journal Link http://www.jbc.org/cgi/content/full/275/2/1241
MedLine Reference 10625669:1126
Sentence In contrast, two MAP kinase inhibitors, PD98059 and UO126, significantly blocked PPAR-gamma phosphorylation (Fig. 6 B ).

Organism Mus musculus
Journal J. Biol. Chem
CellType adipocyte
Journal Reference v277 i48 p46226 (2002)
Journal Link http://www.jbc.org/cgi/content/full/277/48/46226
MedLine Reference 12270934:1157
Sentence Inhibition of this activity by exposure of preadipocytes to the MEK1 inhibitors U0126 or PD98059 significantly attenuates expression of C/EBPalpha and PPARgamma without affecting C/EBPeta expression.

Tissue mesangia
MedLine Reference 15522842:12
Sentence PPARgamma expression induced by 9HODE was also reduced by PD98059 pretreatment.

CellLineName MOCK
MedLine Reference 14750214:5
Sentence A MEK1/2 inhibitor PD98059 induced transcription of both PPARgamma and SSAT genes in the activated Ki-ras clones, suggesting that the mitogen-activated protein kinases (MAPKs) were involved in the regulation of SSAT expression by PPARgamma.